Novo Nordisk Seeks To Block Copycat Versions of Weight Loss Drugs

The maker of weight loss drug Wegovy and diabetes treatment Ozempic is calling on the Food and Drug Administration to prevent compounding pharmacies from manufacturing their own version of the popular drugs.

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.